Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1993 Nov;86(11):634–636. doi: 10.1177/014107689308601107

Temporary prostatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention.

K M Anson 1, D G Barnes 1, T P Briggs 1, G M Watson 1, R A Miller 1
PMCID: PMC1294219  PMID: 8258796

Abstract

Urinary retention secondary to carcinoma of the prostate is usually treated by 'channel' transurethral resection of the prostate either performed alone or in combination with hormone manipulation. The combination of temporary prostatic stenting and androgen suppression may reduce the morbidity and mortality associated with this treatment. We report on our initial experience using the combination of a temporary prostatic stent with the oral anti-androgen Flutamide in 10 patients with urinary retention or severe bladder outflow obstruction secondary to prostatic carcinoma. Eight of the ten patients successfully voided and maintained normal voiding after stent removal. There were two treatment failures requiring prostatic resection. We believe the cost of stenting and medication is entirely justified by patient preference and clearance of hospital beds.

Full text

PDF
634

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birch B. R., Anson K. M., Miller R. A. Sedoanalgesia in urology: a safe, cost-effective alternative to general anaesthesia. A review of 1020 cases. Br J Urol. 1990 Oct;66(4):342–350. doi: 10.1111/j.1464-410x.1990.tb14952.x. [DOI] [PubMed] [Google Scholar]
  2. Fleischmann J. D., Catalona W. J. Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol. 1985 Sep;134(3):498–500. doi: 10.1016/s0022-5347(17)47257-0. [DOI] [PubMed] [Google Scholar]
  3. Harrison N. W., De Souza J. V. Prostatic stenting for outflow obstruction. Br J Urol. 1990 Feb;65(2):192–196. doi: 10.1111/j.1464-410x.1990.tb14698.x. [DOI] [PubMed] [Google Scholar]
  4. Hwang T. I., Yang C. R., Wang S. J., Chang C. L., Tzai T. S., Chang C. H., Wu H. C. Impotence evaluated by the use of prostaglandin E1. J Urol. 1989 Jun;141(6):1357–1359. doi: 10.1016/s0022-5347(17)41306-1. [DOI] [PubMed] [Google Scholar]
  5. Lund F., Rasmussen F. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study. Br J Urol. 1988 Feb;61(2):140–142. doi: 10.1111/j.1464-410x.1988.tb05062.x. [DOI] [PubMed] [Google Scholar]
  6. Mazur A. W., Thompson I. M. Efficacy and morbidity of "channel" TURP. Urology. 1991 Dec;38(6):526–528. doi: 10.1016/0090-4295(91)80170-c. [DOI] [PubMed] [Google Scholar]
  7. Mebust W. K., Holtgrewe H. L., Cockett A. T., Peters P. C. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989 Feb;141(2):243–247. doi: 10.1016/s0022-5347(17)40731-2. [DOI] [PubMed] [Google Scholar]
  8. Nielsen K. K., Klarskov P., Nordling J., Andersen J. T., Holm H. H. The intraprostatic spiral. New treatment for urinary retention. Br J Urol. 1990 May;65(5):500–503. doi: 10.1111/j.1464-410x.1990.tb14795.x. [DOI] [PubMed] [Google Scholar]
  9. Nissenkorn I. Experience with a new self-retaining intraurethral catheter in patients with urinary retention: a preliminary report. J Urol. 1989 Jul;142(1):92–94. doi: 10.1016/s0022-5347(17)38670-6. [DOI] [PubMed] [Google Scholar]
  10. Nordling J., Holm H. H., Klarskov P., Nielsen K. K., Andersen J. T. The intraprostatic spiral: a new device for insertion with the patient under local anesthesia and with ultrasonic guidance with 3 months of followup. J Urol. 1989 Sep;142(3):756–758. doi: 10.1016/s0022-5347(17)38878-x. [DOI] [PubMed] [Google Scholar]
  11. Nordling J., Ovesen H., Poulsen A. L. The intraprostatic spiral: clinical results in 150 consecutive patients. J Urol. 1992 Mar;147(3):645–647. doi: 10.1016/s0022-5347(17)37333-0. [DOI] [PubMed] [Google Scholar]
  12. Poulsen A. L., Ovesen H., Nielsen K. K., Kromann-Andersen B., Nordling J. Intraprostatic spiral during waiting time for transurethral prostatectomy. Urol Int. 1991;46(2):172–175. doi: 10.1159/000282126. [DOI] [PubMed] [Google Scholar]
  13. Sogani P. C., Vagaiwala M. R., Whitmore W. F., Jr Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy. Cancer. 1984 Aug 15;54(4):744–750. doi: 10.1002/1097-0142(1984)54:4<744::aid-cncr2820540426>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  14. Sogani P. C., Whitmore W. F., Jr Experience with flutamide in previously untreated patients with advanced prostatic cancer. J Urol. 1979 Nov;122(5):640–643. doi: 10.1016/s0022-5347(17)56539-8. [DOI] [PubMed] [Google Scholar]
  15. Thomas D. J., Balaji V. J., Coptcoat M. J., Abercrombie G. F. Acute urinary retention secondary to carcinoma of the prostate. Is initial channel TURP beneficial? J R Soc Med. 1992 Jun;85(6):318–319. [PMC free article] [PubMed] [Google Scholar]
  16. Van Poppel H., Baert L., Aswarie H., Oyen R. Experience with the intraprostatic spiral. Br J Urol. 1991 Dec;68(6):604–607. doi: 10.1111/j.1464-410x.1991.tb15423.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES